Sequoia Capital Revolutionizes Open Source Supportby Lilu Anderson 15.02.2024Venture firm Sequoia Capital expands its Open Source Fellowship program to provide financial backing and support for open-source developers. This ...
UK Power Networks Revolutionizes Power Restoration with Drone Technologyby Lilu Anderson 15.02.2024UK Power Networks is pioneering the use of drone technology for power restoration in South East England, offering a safer ...
Alabama Gaming Debate: Kay Ivey Sparks Vote in 2024by Mark Eisenberg 15.02.2024Governor Kay Ivey has announced support for a state-wide gaming vote in Alabama, signaling a potential shift towards legalized gaming, ...
Xponential Fitness: STRIDE Divestiture Driving Growthby Terry Bingman 15.02.2024Xponential Fitness divests STRIDE Fitness brand to optimize portfolio for growth, with no significant impact on 2024 revenue. Aggressive share ...
Stellantis Boosts Italian Production Amid Government Tensionsby Mark Eisenberg 15.02.2024Stellantis CEO Carlos Tavares confirms plans to expand Italian production, aiming to increase automotive output to one million vehicles by ...
MGP Ingredients: Outperform Rating & Wedbush Listby Mark Eisenberg 15.02.2024Investment firm Wedbush reaffirms an Outperform rating for MGP Ingredients, adding the company to its Best Ideas List, indicating a ...
Hawaii leads charge in AI regulation raceby Lilu Anderson 15.02.2024Hawaii state lawmakers are leading efforts to regulate advanced AI technology, aiming to strike a balance between innovation and public ...
Cigna’s $3.2B Buyback: Market Game-Changer?by Mark Eisenberg 15.02.2024Cigna Group announces a $3.2 billion stock buyback program, demonstrating confidence in its financial health and growth prospects. This strategic ...
ZLUDA Project: Disrupting AMD-NVIDIA Rivalry?by John Darbie 15.02.2024The ZLUDA project could disrupt the GPU-based computing market by allowing CUDA applications to run on AMD GPUs, boosting AMD's ...
Wolfe Research Bullish on Roivant Sciences: Outperform Ratingby Mark Eisenberg 15.02.2024Wolfe Research initiates coverage on Roivant Sciences, assigning an outperform rating with a price target of $17.00. Their analysis highlights ...